Skip to main content


Fig. 6 | Cardiovascular Diabetology

Fig. 6

From: Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials

Fig. 6

Effect of aspirin on the primary prevention of major adverse cardiovascular events according to relevant clinical characteristics, based on pooled analysis of individual level data from three trials. BP, blood pressure; CI, confidence interval (bars); OR, odds ratio; RA, rheumatoid arthritis

Back to article page